BioSpace News Archive

Drug Development

With Robust Results, Moderna to Request Vaccine EUA for Kids Under 6

Moderna reported positive interim results from the Phase II/III KidCOVE trial of its mRNA COVID-19 vaccine for children six months to under two years and two to six years of age.

March 23, 2022
·
2 min read
·
Mark Terry
Business

Merck Bids Fond Farewell to Roy Baynes who Joins Eikon

Merck has announced the retirement of Dr. Roy D. Baynes, head of global clinical development and chief medical officer of Merck Research Laboratories.

March 23, 2022
·
3 min read
·
Hayley Shasteen
Policy

Fraud Trial of Former Theranos Executive Ramesh’ Sunny’ Balwani Begins

Like Elizabeth Holmes, Ramesh Balwani faces multiple counts of fraud related to the business practices of Theranos.

March 23, 2022
·
2 min read
·
Alex Keown
Drug Development

Argenx Myasthenia Gravis Drug Demonstrates Versatility In Phase III Trial

Data from the Phase III study showed that efgartigimod achieved the primary endpoint of total IgG reduction from the baseline on the 29th day of observation.

March 23, 2022
·
2 min read
·
Vanessa Doctor, RN
Pfizer Issues Recall for Blood Pressure Medications Containing Nitrosamine

Pfizer issued a statement on Monday regarding a voluntary recall of three of its products. The recall affects eleven lots of hypertension medications in total.

March 23, 2022
·
2 min read
·
Jazmine Colatriano
Money on the Move: March 16-22

Most major money moves this week were related to immune therapy companies, including rounds of funding for T cell therapies, allergy therapies and immunomodulation platforms.

March 23, 2022
·
2 min read
·
Hannah Chudleigh
GSK-Backed LifeMine Nets $175M and More Financing News

Read on to learn more about three Series B and C financing rounds in the areas of genetically encoded small molecules, artificial intelligence (AI) and immuno-oncology (IO).

March 23, 2022
·
3 min read
·
Mark Terry
Drug Development

Neurana, Aurobindo and ORIC Face Tough Decisions, Layoffs

Neurana Pharmaceuticals is facing dire financial straits following the failure of its Phase III treatment for muscle spasm relief associated with an acute, painful musculoskeletal condition.

March 23, 2022
·
2 min read
·
Alex Keown
Drug Development

Brain Implant Gives ALS Patient A Voice: “I Love My Cool Son”

A man paralyzed from amyotrophic lateral sclerosis (ALS) now has the ability to spell out his thoughts, thanks to an implanted electrode device that reads his brain signals.

March 23, 2022
·
3 min read
·
Hannah Chudleigh
Deals

FUJIFILM Enhances Life Sciences Arm with Shenandoah Buy

Shenandoah Biotechnology is a Warminster, Pennsylvania-based firm that manufactures recombinant proteins, including growth factors and cytokines.

March 23, 2022
·
2 min read
·
Vanessa Doctor, RN